Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update

Despite efforts to improve earlier diagnosis of non-small cell lung cancer (NSCLC), most patients present with advanced stage disease, which is often associated with poor survival outcomes with only 15% surviving for 5 years from their diagnosis. Tumour tissue biopsy is the current mainstream for ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapeleris, Joanna, Ebrahimi Warkiani, Majid, Kulasinghe, Arutha, Vela, Ian, Kenny, Liz, Ladwa, Rahul, O’Byrne, Kenneth, Punyadeera, Chamindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965052/
https://www.ncbi.nlm.nih.gov/pubmed/35372000
http://dx.doi.org/10.3389/fonc.2022.859152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965052/
https://www.ncbi.nlm.nih.gov/pubmed/35372000
http://dx.doi.org/10.3389/fonc.2022.859152

Ejemplares similares